Healthcare orgs given extra time to comply with price transparency

The Biden administration has given healthcare organizations extra time to comply with a price transparency rule.

The Trump-era rule, called Transparency in Coverage, aims to ensure patients know how much they will owe when they go to the doctor or undergo certain procedures or treatments. The rule was originally slated to go into effect Jan. 1, 2022, with health plans and insurers required to disclose on a public website information regarding:

  • In-network provider rates for covered items and services
  • Out-of-network allowed amounts and billed charges for covered items and services
  • Negotiated rates and historical net prices for covered prescription drugs

However, healthcare organizations now have until July 1, 2022, to comply and post in-network rates and out-of-network allowed amounts. Other provisions of the rule, including the publication of prescription drug costs, will also not be enforced indefinitely. That’s because stakeholders expressed concern over duplicate rules and a changed regulatory landscape since the rule was first published.

The rule intends to help consumers understand healthcare costs better, with the aim that consumers will shop around for the best price and quality. However, studies have shown consumers don’t really shop around when it comes to healthcare. 

The Trump administration published another price transparency rule that forced hospitals to publish their prices of the most common procedures. Despite going into effect, only a small percentage of hospitals have complied with the rules. The lack of compliance has prompted HHS to consider higher civil penalty fines.

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Compensation for heart specialists continues to climb. What does this say about cardiology as a whole? Could private equity's rising influence bring about change? We spoke to MedAxiom CEO Jerry Blackwell, MD, MBA, a veteran cardiologist himself, to learn more.

The American College of Cardiology has shared its perspective on new CMS payment policies, highlighting revenue concerns while providing key details for cardiologists and other cardiology professionals. 

As debate simmers over how best to regulate AI, experts continue to offer guidance on where to start, how to proceed and what to emphasize. A new resource models its recommendations on what its authors call the “SETO Loop.”